Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

Non-alcoholic fatty liver disease (NAFLD) parallels comorbidities such as metabolic
syndrome, dyslipidaemia or diabetes. Although NAFLD is very prevalent in overweight …

Non-alcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese subjects;
however, it is not rare among lean individuals. Given the absence of traditional risk factors, it …

Nonalcoholic fatty liver disease (NAFLD) accounts for most cases of chronic liver disease
worldwide, with an estimated global prevalence of approximately 25% and ranges from …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Background & aims Non-alcoholic fatty liver disease (NAFLD), with its increasing prevalence
and association with various co-morbidities, such as diabetes, cardiovascular disease and …

Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of liver abnormalities from
benign steatosis to nonalcoholic steatohepatitis (NASH). NASH is characterized by chronic …

Nonalcoholic fatty liver disease (NAFLD) refers to a group of conditions characterized by
hepatic steatosis in the absence of significant alcohol consumption. NAFLD is seen …

Objective As a subgroup of nonalcoholic fatty liver disease (NAFLD), patients with non‐
obese NAFLD may also have an increased risk of adverse hepatic and metabolic outcomes …